Q1 2023 Performance - Comparable currency neutral sales increased by 1%[9, 41] - Comparable currency neutral adjusted operating EBITDA decreased by 19%[9, 28] - Comparable currency neutral adjusted operating EBITDA ex Absorption decreased by 4%[11] - Adjusted Operating EBITDA was $503 million[25, 28] - Net Debt to Credit Adjusted EBITDA was 4.6x[25, 45] - Q1 2023 sales were $3.0 billion[25] FY 2023 Outlook (Revised) - Revenue is expected to be approximately $12.3 billion[34] - Comparable currency neutral sales growth is expected to be approximately 5%[34] - Adjusted operating EBITDA is expected to be approximately $2.34 billion[34] - Comparable currency neutral adjusted operating EBITDA growth is expected to be approximately 0%[34]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number 1-4858 INTERNATIONAL FLAVORS & FRAGRANCES INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction o ...

International Flavors & Fragrances Inc. (NYSE:IFF) Q4 2022 Earnings Conference Call February 9, 2023 9:00 AM ET Company Participants Michael DeVeau – Head Investor Relations Frank Clyburn – Chief Executive Officer Glenn Richter – Executive Vice President, Chief Financial Officer Conference Call Participants Heidi Vesterinen – BNP Paribas Gunther Zechmann – Bernstein Mike Sison – Wells Fargo Josh Spector – UBS Ghansham Panjabi – Baird John Roberts – Credit Suisse David Begleiter – Deutsche Bank Mark Astracha ...

CONSOLIDATED OUTLOOK FY 2023 ADJUSTED OPERATING EBITDA¹ RECONCILIATION Year-over-year change $2.37B 1 Non-GAAP metric; please see Non-GAAP disclosures at ir.iff.com ² Approximately $85 million of adjusted operating EBITDA related to the impact of divestitures and acquisitions * Based on current market foreign exchange rates 1 Accelerate sales growth FOCUS AREA ACTION PLAN SUMMARY ____ | --- | --- | |---------------------------------|-------| | | | | | | | C | | | Where science & creativity meet | | CAUTIONA ...

International Flavors & Fragrances Inc. (NYSE:IFF) Q3 2022 Earnings Conference Call November 8, 2022 9:00 AM ET Company Participants Michael DeVeau - Head of Investor Relations Frank Clyburn - Chief Executive Officer Glenn Richter - Executive Vice President & Chief Financial Officer Conference Call Participants Adam Samuelson - Goldman Sachs Mark Astrachan - Stifel John Roberts - Credit Suisse Gunther Zechmann - Bernstein Heidi Vesterinen - BNP Paribas Anthony Mercandetti - Deutsche Bank Mike Sison - Wells ...

Financial Performance - Q3 2022 - Revenue was \$3.063 billion, a 0% change year-over-year[24] - Adjusted operating EBITDA was \$612 million, a decrease of 6%[24] - Adjusted operating EBITDA margin was 20%, a decrease of 110 basis points[24] - Adjusted EPS ex amortization was \$1.36, a decrease of 7%[24] - Comparable currency neutral sales increased by 10%[23, 26] - Comparable adjusted currency neutral operating EBITDA increased by 3%[23, 28] - Foreign exchange had an adverse impact of approximately 7 percentage points on sales and 8 percentage points on adjusted operating EBITDA[23] Financial Performance - 9M YTD 2022 - Sales reached \$9.6 billion[22] - Comparable currency neutral sales increased by 11%[22] - Adjusted Operating EBITDA was \$2.0 billion[22] - Over \$875 million in price increases were achieved to recover total inflation[22] - Productivity savings exceeded \$125 million in operational efficiencies and deal-related synergies[22] - Net Debt to Credit Adjusted EBITDA was 3.9x[22] Cash Flow & Leverage - Cash flow from operations totaled \$189 million[33] - Capital expenditures were \$344 million, approximately 3.6% of sales[33] - Free cash flow generation was \$(155) million[33] - Dividends paid amounted to \$604 million[33] - Cash and cash equivalents finished at \$538 million[33] - Gross debt totaled \$10.812 billion[33] - Trailing 12-month credit adjusted EBITDA totaled \$2.614 billion[33] - Net debt to credit adjusted EBITDA was 3.9x[33] Full Year 2022 Outlook - Sales are projected to be in the range of \$12.4 to \$12.5 billion[35] - Currency neutral comparable sales growth is expected to be 9% to 10%[35] - Adjusted operating EBITDA is projected to be in the range of \$2.5 to \$2.6 billion[35] - Currency neutral comparable adjusted operating EBITDA growth is expected to be 4% to 8%[35] - Currency is expected to have an adverse impact of approximately 5 percentage points on sales and 6 percentage points on adjusted operating EBITDA[34]

FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 For the transition period from to Commission file number 1-4858 INTERNATIONAL FLAVORS & FRAGRANCES INC. (Exact name of registrant as specified in its charter) New York 13-1432060 (State or other j ...

Financial Data and Key Metrics Changes - In Q2 2022, IFF generated over $3 billion in sales, representing an 11% year-over-year increase on a comparable currency-neutral basis, primarily driven by double-digit growth in Nourish and Pharma solutions [44] - Sales for the first half of 2022 grew by 18% or 12% on a currency-neutral basis to $6.5 billion, with comparable currency-neutral adjusted operating EBITDA growing 8% to $1.4 billion [40] - Adjusted operating EBITDA for Q2 was $700 million, exceeding expectations and representing 7% year-over-year comparable currency-neutral growth [51] Business Line Data and Key Metrics Changes - Nourish was the largest growth driver, achieving year-over-year comparable currency-neutral sales growth of 15% and 18% growth in comparable currency-neutral adjusted operating EBITDA [53] - Health & Biosciences delivered 4% comparable currency-neutral sales growth, while Scent achieved 9% growth, although Scent faced a 17% decrease in comparable currency-neutral adjusted operating EBITDA due to inflationary pressures [48][54] - Pharma Solutions achieved 10% year-over-year comparable currency-neutral sales growth and a 25% increase in comparable currency-neutral adjusted operating EBITDA [55] Market Data and Key Metrics Changes - The company reported that foreign exchange rates adversely impacted sales and EBITDA in Q2, with expectations of foreign exchange pressures impacting sales by approximately 5 percentage points [60][62] - The company noted that China, as its second-largest market, experienced demand weakness due to lockdowns, affecting overall performance [113] Company Strategy and Development Direction - IFF is focused on a strategic refresh to ensure long-term profitable growth, including a more data-driven resource allocation strategy and enhancing productivity programs [11][15] - The company completed the divestiture of its Microbial Control business and is evaluating additional non-core divestitures to improve capital structure [16][42] - IFF aims to strengthen its culture and attract top talent to drive execution of its strategic plan [19][17] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the portfolio's resilience despite macroeconomic challenges, with a focus on productivity and pricing actions to recover inflation costs [115][116] - The company reaffirmed its full-year guidance, projecting sales of $12.6 billion to $13 billion and currency-neutral sales growth of 9% to 12% [60][62] - Management acknowledged the challenges posed by inflation and supply chain disruptions but remains committed to delivering value to stakeholders [70][72] Other Important Information - IFF increased its quarterly dividend by approximately 3%, marking the 13th consecutive year of increased payouts to shareholders [41][59] - The company is targeting a preliminary net annualized P&L impact of $250 million to $300 million from its productivity programs, expected to be achieved between 2023 and 2025 [32][33] Q&A Session Summary Question: Productivity program and balancing margin versus volume growth - Management emphasized the importance of the productivity program for sustainable, profitable growth and leveraging it for future investments [77] Question: Q2 currency-neutral growth and volume performance - Management noted that while volume growth was modest, core businesses performed well, and the focus remains on balancing volume and profitability [81][82] Question: Volume contribution within Nourish and inflation forecast - Management highlighted strong performance in Nourish and indicated that inflationary pressures are expected to continue into 2023, particularly in raw materials [88][91] Question: Free cash flow performance and inventory levels - Management acknowledged higher inventory levels impacting free cash flow and indicated efforts to improve efficiencies in the second half of the year [96][98] Question: Price-cost balance and inflation management - Management discussed the ongoing efforts to capture price increases and the challenges posed by inflation, indicating a potential lag in recovery [100][102] Question: Demand weakness and macroeconomic slowdown strategies - Management identified China as a region experiencing demand weakness and emphasized the importance of productivity and customer engagement as strategies to navigate potential downturns [113][116]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-4858 INTERNATIONAL FLAVORS & FRAGRANCES INC. (Exact name of registrant as specified in its charter) New York 13-1432060 (State or other jurisd ...

International Flavors & Fragrances Inc. (NYSE:IFF) Q1 2022 Earnings Conference Call May 10, 2022 9:00 AM ET Company Participants Michael DeVeau - Senior Vice President, Chief Investor Relations and Communications Officer Frank Clyburn - Chief Executive Officer Glenn Richter - Executive Vice President and Chief Financial Officer Conference Call Participants Gunther Zechmann - Sanford C. Bernstein & Co., LLC Ghansham Panjabi - Robert W. Baird & Co. Jonathan Feeney - Consumer Edge Research Mark Astrachan - Sti ...